Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Regional Development
  • Published:

Not enough biotechs, and what government can do about it

Nature Biotechnology volume 17, pages 35–36 (1999)Cite this article

Abstract

While financial markets may believe there are too many biotechnology companies in the world, research suggests that the opposite is true.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. development manager for the biotechnology group at Scottish Enterprise, 120 Bothwell Street, Glasgow, G2 7JP, UK

    Kevin Bazley

Authors
  1. Kevin Bazley
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bazley, K. Not enough biotechs, and what government can do about it. Nat Biotechnol 17 (Suppl 3), 35–36 (1999). https://doi.org/10.1038/9108

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/9108

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing